Chronic Kidney Disease Clinical Trials in Toronto, Ontario
7 recruitingToronto, Ontario, Canada
Showing 1–7 of 7 trials
Recruiting
Phase 2
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
Chronic Kidney Disease
Boehringer Ingelheim416 enrolled153 locationsNCT06926660
Recruiting
Phase 3
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
Chronic Kidney Disease
Boehringer Ingelheim120 enrolled102 locationsNCT07107945
Recruiting
Phase 3
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Chronic Kidney DiseaseProteinuriaChildren
Bayer100 enrolled178 locationsNCT05457283
Recruiting
Phase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
AstraZeneca5,000 enrolled753 locationsNCT06742723
Recruiting
Phase 2
Ferric Citrate and Chronic Kidney Disease in Children
Chronic Kidney Diseases
University of California, Los Angeles160 enrolled20 locationsNCT04741646
Recruiting
Not Applicable
ODYSSEE Kidney Health Trial
Chronic Kidney Diseases
University Health Network, Toronto344 enrolled1 locationNCT06274710
Recruiting
KIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors (CCS)
HypertensionChronic Kidney DiseasesAcute Kidney Injury+2 more
The Hospital for Sick Children500 enrolled1 locationNCT06153147